Journal News

New mass spectrometry tool accurately identifies bacteria

Ecem Arpaci
By Ecem Arpaci
April 30, 2025

Scientists identify bacterial species by analyzing their proteins using mass spectrometry, or MS. This technique first fragments proteins into smaller peptides using an enzyme called trypsin. These sequences can then be compared to references in databases. The largest MS-based studies on bacteria have focused on just a handful of species, so a team of researchers recently created a resource for mapping data onto a more diverse population of bacteria.

Miriam Abele, Armin Soleymaniniya and colleagues at the Technical University of Munich developed MS2Bac, a software system that enables bacterial identification from protein data. They published their resource in Molecular & Cellular Proteomics. MS2Bac maps tryptic peptides onto reference bacterial species or strains, achieving almost perfect accuracy for species identification. To develop this tool, the team first performed MS on the proteins from over 300 bacterial species to create a reference database. They also compared their identification method with other approaches, such as Fourier transform infrared spectroscopy, and found that MS2Bac was the most accurate.

MS2Bac can also identify specific proteins, antibiotic resistance markers. It covers many hypothetical proteins, which are not well understood, providing a basis for further functional studies. This is the first study to incorporate single-cell organisms into the ProteomicsDB database, a proteomics resource for multiomics analyses. This tool will greatly help researchers and clinicians determine bacterial species from clinically and environmentally relevant samples.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ecem Arpaci
Ecem Arpaci

Ecem Arpaci is a biochemistry student at Imperial College London and a research intern at Radboud University Medical Center. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Glaucoma model links immune signaling to disease progression
Journal News

Glaucoma model links immune signaling to disease progression

June 4, 2026

Researchers at Duke University determine genetic variations that could increase the risk of developing glaucoma.

Uncovering the molecular roots of fatty liver disease
Interview

Uncovering the molecular roots of fatty liver disease

June 3, 2026

Physician–scientist Silvia Sookoian discusses her path from hepatitis C care to MASLD research, her use of multi-omics to study steatotic liver disease, and how lipid metabolism and genetics are reshaping understanding of MASH and liver health.

Mitochondria shape kidney cell function
Journal News

Mitochondria shape kidney cell function

May 28, 2026

Researchers at the University of Washington, Seattle present the first quantitative comparison of mitochondrial interactomes between two epithelial cell types in the kidney.

Long-chain polyunsaturated fatty acids linked to postoperative delirium risk
Journal News

Long-chain polyunsaturated fatty acids linked to postoperative delirium risk

May 27, 2026

Researchers show that altered lipid metabolism may contribute to postoperative delirium, a condition linked to increased risk for long-term cognitive decline. The study explores potential disease mechanisms, which have yet to be understood.

Glycosylation patterns across antibody isotypes distinguish tuberculosis states
Journal News

Glycosylation patterns across antibody isotypes distinguish tuberculosis states

May 26, 2026

Researchers at Taipei Medical University present the first site-specific glycosylation analysis of immunoglobulins in elderly tuberculosis patients.

Blood glycome possibly predicts lifespan
Journal News

Blood glycome possibly predicts lifespan

May 21, 2026

Researchers at the University of Santiago de Compostela show that total serum N-glycome can predict mortality independent of traditional risk factors.